Lilly to buy sleep disorder drug company

March 5, 2007

Eli Lilly and Co. has agreed to buy Hypnion Inc., a Lexington, Mass., neuroscience drug research firm focused on sleep disorder. Financial terms were not disclosed. The acquisition is expected to close by the end of the month.

Source: XMLFULL/XMLFull824.xml

Recent Articles by IBJ Staff

Comments powered by Disqus